AMNEAL PHARMACEUTICALS, INC. (AMRX)
Amneal Announces U.S. FDA Approval of Romidepsin Injection Solution
Amneal Announces U.S. FDA Approval of Romidepsin Injection Solution
Drew Brees Collaborates with ARS Pharmaceuticals to Raise Awareness About Living Life with Severe Allergies
Arvinas Joins The Michael J. Fox Foundation’s LITE and PPMI Programs to Advance New Therapies Targeting LRRK2 for Parkinson’s Disease
PepsiCo Announces Timing and Availability of Second-Quarter 2026 Financial Results
Daré Bioscience Announces the Upcoming Launch of Flora Sync LF5™ Vaginal Probiotic Capsules
Diginex Expands Supply Chain End-to-End Product Suite Amid Accelerating Regulatory Pressure
Pure Harvest Corporate Group (OTC: PHCG), Operating as Mixie Technologies, Announces HoloTwin 2.0 Framework for Large-Scale 3D Visualization in the Browser
Immutep to Present Positive Interim Phase I Data for IMP761, a First-in-Class LAG-3 Agonist Antibody, at EULAR 2026
VCI Global Provides Strategic Business Update as Institutional Shareholder Base Expands
IMUNON Announces Up to $10 Million Cash Financing